So it was just gibberish? What the hell is he even talking about?
In recent weeks, Biden has demanded that Trump "speed up the testing" nationwide
www.foxnews.com
The nasal mist version of the vaccine started shipping on 1 October 2009.
Around three billion doses were produced, with delivery in November 2009
And were ne
So it was just gibberish? What the hell is he even talking about?
In recent weeks, Biden has demanded that Trump "speed up the testing" nationwide
www.foxnews.com
The nasal mist version of the vaccine started shipping on 1 October 2009.
Around three billion doses were produced, with delivery in November 2009
let’s look at the facts-
Oct 16, 2009 (CIDRAP News) – Production delays are cutting into federal pandemic vaccine–supply projections at a time when virus activity is widespread in 41 states and children's deaths are spiraling, the US Centers for Disease Control and Prevention (CDC) said today.
Since August, federal officials have predicted that 45 million pandemic vaccine doses would be available by mid October, but today the CDC said the total so far is 11.4 million.
The slow start is complicating the launch of pandemic flu vaccine campaigns for state and local public health departments as well as school districts. Some have postponed or cancelled events because they don't know when they will receive their vaccine supplies. For example, the Lawrence-Douglas County Health Department, based in Lawrence, Kansas, recently cancelled Oct 30 clinics at the fairgrounds and the University of Kansas because it wasn't sure when the vaccine would arrive.
US H1N1 vaccine delayed as cases and deaths rise
Vaccine production delays led to a supply of vaccine that was slower than expected. The first doses were administered to the public on October 5, 2009, but the supply of vaccine during the first 2 months of the program was not sufficient to cover the target groups for whom the ACIP had recommended vaccination. Adding to this difficulty, the majority of the vaccine that was initially available was Live-Attenuated Influenza Vaccine (LAIV), which was contraindicated for the very young, for those with certain conditions such as asthma, and for pregnant women—among the target groups considered highest priority. Further, many healthcare workers were reluctant to receive LAIV, often because of unfounded concerns about transmission to patients in healthcare settings and vaccine efficacy. This is discussed in more detail below. Unfortunately, this limited supply of vaccine occurred when demand for vaccine was at its highest and around the time of the peak of the fall 2009 wave of influenza.
We prepared for being able to move as much vaccine as quickly as possible and really were concerned that there would be a glut of vaccine. What we had to deal with then was a trickle, and a trickle that really continued for a number of weeks.” David Fleming, director and health officer for Public Health–Seattle & King County, agreed, saying, “We spent months planning for a response where the rate-limiting step was going to be the vaccine distribution system, and that’s not what happened.” For this reason, Fleming continued, “It is important to go back and critically look at . . . the system that allowed us as a nation to miss for so long that the fundamental problem we were going to be facing was a vaccine shortage.”
Vaccine Supply - The 2009 H1N1 Influenza Vaccination Campaign - NCBI Bookshelf
2009 swine flu pandemic vaccine - Wikipedia
By April 2010, it was apparent that most of the vaccine was not needed. The US government had bought 229 million doses of H1N1 vaccines of which 91 million doses were used; of the surplus, some of it was stored in bulk, some of it was sent to developing countries and 71 million doses were destroyed.[132] The
World Health Organization is planning to examine if it overreacted to the H1N1 outbreak.[132]
